ERBB2 and breast cancer: Several factors promoting or affecting breast cancer pathogenesis, such as Her2/neu, estrogen and progesterone receptors, E-cadherin, vascular endothelial growth factor, and BRCA1 have been identified and are useful as prognostic indicators or therapeutic targets [65-67].